Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
All about CAR T in multiple myeloma
Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber Cancer Institute
Autologous stem cell transplant is a widely used treatment in myeloma. Learn how advances are making it easier and how it's being used in the age of immunother
The cure for myeloma won't come about magically. Patients can be active participants in the research process.
Why is MRD testing so important for the myeloma patient? Learn more in this important show
Understanding Blood-Based Mass Spec and MRD Testing in Multiple Myeloma
A new treatment called modafakusp alpha is now in Phase II clinical trials targeting CD38 in myeloma
Innovations in Multiple Myeloma: Looking into 2023
Learn more about the first bispecific antibody to be approved in multiple myeloma, teclistamab
Learn more about kidney disease as it relates to multiple myeloma with Natalie Callander, MD